Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP735219.RAxEw6GgizjI-cFIHycxnY5Tv3R62oqlPiIrQtdjoUe9A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP735219.RAxEw6GgizjI-cFIHycxnY5Tv3R62oqlPiIrQtdjoUe9A130_assertion type Assertion NP735219.RAxEw6GgizjI-cFIHycxnY5Tv3R62oqlPiIrQtdjoUe9A130_head.
- NP735219.RAxEw6GgizjI-cFIHycxnY5Tv3R62oqlPiIrQtdjoUe9A130_assertion description "[Taken together, our findings suggest that SRC-1 switches steroid-responsive tumors to a steroid-resistant state in which the SRC-1 target gene ADAM22 has a critical role, suggesting this molecule as a prognostic and therapeutic drug target that could help improve the treatment of endocrine-resistant breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP735219.RAxEw6GgizjI-cFIHycxnY5Tv3R62oqlPiIrQtdjoUe9A130_provenance.
- NP735219.RAxEw6GgizjI-cFIHycxnY5Tv3R62oqlPiIrQtdjoUe9A130_assertion evidence source_evidence_literature NP735219.RAxEw6GgizjI-cFIHycxnY5Tv3R62oqlPiIrQtdjoUe9A130_provenance.
- NP735219.RAxEw6GgizjI-cFIHycxnY5Tv3R62oqlPiIrQtdjoUe9A130_assertion SIO_000772 22072566 NP735219.RAxEw6GgizjI-cFIHycxnY5Tv3R62oqlPiIrQtdjoUe9A130_provenance.
- NP735219.RAxEw6GgizjI-cFIHycxnY5Tv3R62oqlPiIrQtdjoUe9A130_assertion wasDerivedFrom befree-20140225 NP735219.RAxEw6GgizjI-cFIHycxnY5Tv3R62oqlPiIrQtdjoUe9A130_provenance.
- NP735219.RAxEw6GgizjI-cFIHycxnY5Tv3R62oqlPiIrQtdjoUe9A130_assertion wasGeneratedBy ECO_0000203 NP735219.RAxEw6GgizjI-cFIHycxnY5Tv3R62oqlPiIrQtdjoUe9A130_provenance.